EU GMP Annex 1, which governs the manufacture of sterile products has been changed. The revised guidelines came into effect October 1st 2024 and will have a broad impact on industries dealing with sterile production.
Key Changes:
- Quality Risk Management (QRM): The revised Annex 1 emphasizes the use of QRM principles in sterile manufacturing, making it mandatory to identify and control risks throughout the production process.
- Contamination Control Strategy (CCS): Companies are now required to implement a comprehensive CCS that integrates environmental monitoring, equipment design, and operational practices to minimize the risk of contamination.
- Process Automation: The revised guidelines encourage the adoption of automation and digital solutions to improve process control and reduce human intervention in sterile areas.
Impact: Sterile product manufacturers need to enhance their risk management strategies and embrace automation to meet the stricter Annex 1 guidelines.
